HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
scientific article published on 20 April 2017
Author/s
author: Cliona M Rooney, Malcolm Brenner, Helen Heslop, Adrian P Gee, Oumar Diouf, Bambi Jo Grilley, Gianpietro Dotti, Jack Meng-Fen Su, Stephen Gottschalk, Claudia Gerken, Kevin Bielamowicz, Meenakshi Hegde, Winfried S Wels, Mamta Kalra, Vita S Brawley, Alexia Ghazi, Aidin Ashoori, Yvonne Kew, Amanda Wakefield
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.